PBH Stock - Prestige Consumer Healthcare Inc.
Unlock GoAI Insights for PBH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.14B | $1.13B | $1.13B | $1.09B | $943.37M |
| Gross Profit | $634.46M | $624.45M | $625.29M | $620.65M | $547.47M |
| Gross Margin | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% |
| Operating Income | $336.77M | $342.43M | $-22,415,000 | $329.92M | $297.40M |
| Net Income | $214.60M | $209.34M | $-82,306,000 | $205.38M | $164.68M |
| Net Margin | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% |
| EPS | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 |
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 24th 2025 | Sidoti | Upgrade | Buy | $80 |
| December 9th 2024 | Sidoti | Downgrade | Neutral | $90 |
| June 21st 2024 | DA Davidson | Upgrade | Buy | $93← $65 |
| November 17th 2022 | Canaccord Genuity | Initiation | Buy | $71 |
| May 10th 2022 | Jefferies | Upgrade | Buy | $70← $65 |
| May 9th 2022 | Oppenheimer | Upgrade | Outperform | $63 |
Earnings History & Surprises
PBHEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | $1.16 | — | — | — |
Q4 2025 | Nov 6, 2025 | $0.97 | $1.07 | +10.3% | ✓ BEAT |
Q3 2025 | Aug 7, 2025 | $1.01 | $0.95 | -5.9% | ✗ MISS |
Q2 2025 | May 8, 2025 | $1.30 | $1.32 | +1.5% | ✓ BEAT |
Q1 2025 | Feb 6, 2025 | $1.16 | $1.22 | +5.2% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $1.08 | $1.09 | +0.9% | ✓ BEAT |
Q3 2024 | Aug 8, 2024 | $0.86 | $0.90 | +4.7% | ✓ BEAT |
Q2 2024 | May 14, 2024 | $1.14 | $0.98 | -14.0% | ✗ MISS |
Q1 2024 | Feb 8, 2024 | $1.04 | $1.06 | +1.9% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $1.07 | $1.07 | 0.0% | = MET |
Q3 2023 | Aug 3, 2023 | $1.01 | $1.06 | +5.0% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $1.04 | $1.07 | +2.9% | ✓ BEAT |
Q1 2023 | Feb 2, 2023 | $1.01 | $1.04 | +3.0% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $1.00 | $1.02 | +2.0% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $1.04 | $1.09 | +4.8% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.89 | $0.91 | +2.2% | ✓ BEAT |
Q1 2022 | Feb 3, 2022 | $0.88 | $0.99 | +12.5% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.99 | $1.02 | +3.0% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $0.87 | $1.14 | +31.0% | ✓ BEAT |
Latest News
Canaccord Genuity Maintains Buy on Prestige Consumer, Lowers Price Target to $88
➖ NeutralPrestige Consumer Raises FY2026 Adj EPS Guidance from $4.50-$4.58 to $4.54-$4.58 vs $4.51 Est; Affirms FY2026 Sales Guidance of $1.100B-$1.115B vs $1.104B Est
📈 PositivePrestige Consumer Q2 2026 Adj. EPS $1.07 Beats $0.97 Estimate, Sales $274.114M Beat $257.170M Estimate
📈 PositiveJefferies Maintains Hold on Prestige Consumer, Lowers Price Target to $71
➖ NeutralOppenheimer Maintains Outperform on Prestige Consumer, Lowers Price Target to $72
➖ NeutralFrequently Asked Questions about PBH
What is PBH's current stock price?
What is the analyst price target for PBH?
What sector is Prestige Consumer Healthcare Inc. in?
What is PBH's market cap?
Does PBH pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PBH for comparison